Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available therapies have undergone considerable development in the past decades, the five-year survival rate for lung cancer remains low. This sobering outlook results mainly from the advanced stages of cancer most patients are diagnosed with. As the population at risk is relatively well defined and early stage disease is potentially curable, lung cancer outcomes may be improved by screening. Several studies already show that lung cancer screening (LCS) with low-dose computed tomography (LDCT) reduces lung cancer mortality. However, for a successful implementation of LCS programmes, several challenges have to be overcome: selection of high-risk indivi...
International audienceEarly-stage treatment improves prognosis of lung cancer and two large randomiz...
Two large-scale RCTs have shown computed tomography (CT) lung cancer screening to be efficacious in ...
Lung cancer screening with low-dose computed tomography can reduce death from lung cancer by 20–24% ...
Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available...
For decades, lung cancer has been the most common cancer in terms of both incidence and mortality. T...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, ...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
Although there is now strong evidence for the efficacy of low-radiation dose computed tomography in...
Lung cancer is the most frequent cause of tumor-associated death and only has a good prognosis if de...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
The discussion about setting up a program for lung cancer screening was launched with the publicatio...
Lung cancer is a leading cause of death worldwide. Patients are usually diagnosed at an advanced sta...
International audienceEarly-stage treatment improves prognosis of lung cancer and two large randomiz...
Two large-scale RCTs have shown computed tomography (CT) lung cancer screening to be efficacious in ...
Lung cancer screening with low-dose computed tomography can reduce death from lung cancer by 20–24% ...
Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available...
For decades, lung cancer has been the most common cancer in terms of both incidence and mortality. T...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, ...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
Although there is now strong evidence for the efficacy of low-radiation dose computed tomography in...
Lung cancer is the most frequent cause of tumor-associated death and only has a good prognosis if de...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
Recent randomised trials on screening with low-dose CT have shown important reductions in lung cance...
The discussion about setting up a program for lung cancer screening was launched with the publicatio...
Lung cancer is a leading cause of death worldwide. Patients are usually diagnosed at an advanced sta...
International audienceEarly-stage treatment improves prognosis of lung cancer and two large randomiz...
Two large-scale RCTs have shown computed tomography (CT) lung cancer screening to be efficacious in ...
Lung cancer screening with low-dose computed tomography can reduce death from lung cancer by 20–24% ...